News tagged with oncology
Related topics: cancer , chemotherapy , breast cancer , radiation oncology , journal of clinical oncology
Scientists eradicate lung tumors in a pre-clinical mouse model
The study, led by the Vall d'Hebron Institute of Oncology (VHIO), has managed to eliminate mouse lung tumours by inhibiting Myc, a protein that plays a key role in the development of many different tumours. The results, to ...
Cancer
Mar 07, 2013 |
5 / 5 (1) |
0
Comparing combination therapies for advanced head and neck cancer shows no improvement
Locally advanced squamous cell carcinoma of the head and neck is a potentially curable disease in nearly every patient at the time of diagnosis, yet despite the most aggressive efforts, up to 30-50 percent ...
Cancer
Mar 07, 2013 |
1 / 5 (1) |
0
The right dose for oncology
EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.
Cancer
Mar 04, 2013 |
2 / 5 (2) |
0
Oestrogen patches could offer a new treatment option for prostate cancer patients
Patches giving oestrogen through the skin could be an easy and safe alternative to the hormone therapies used to treat prostate cancer, according to new research published in the Lancet Oncology, today (Monday).
Cancer
Mar 04, 2013 |
not rated yet |
0
New research challenges notion of using Herceptin only for HER2-positive breast cancer
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative – and that ...
Cancer
Feb 26, 2013 |
not rated yet |
0
|
Novel chemotherapies more often used on- than off-label
(HealthDay)—In contemporary practice, medical oncologists use novel anticancer agents on-label more often than off-label, according to a study published online Feb. 19 in the Journal of Clinical Oncology.
Cancer
Feb 26, 2013 |
5 / 5 (1) |
0
Small molecules in the blood might gauge radiation effects after exposure
Ohio State University cancer researchers have identified molecules in the bloodstream that might accurately gauge the likelihood of radiation illness after exposure to ionizing radiation.
Cancer
Feb 25, 2013 |
5 / 5 (1) |
0
|
Adding elesclomol to paclitaxel for advanced melanoma studied
(HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to ...
Cancer
Feb 22, 2013 |
not rated yet |
0
Greater representation of elderly patients in Phase III trials are needed
The median age of patients diagnosed with advanced non–small-cell lung cancer (NSCLC) has steadily increased over the recent years and is presently 70 years. Despite this, the elderly are significantly underrepresented ...
Cancer
Feb 22, 2013 |
not rated yet |
0
Local therapy followed by treatment with EGFR TKI is well tolerated
Local therapy is not commonly utilized in metastatic lung cancer. Researchers at Memorial Sloan-Kettering Cancer Center investigated the efficacy of local therapy with continued EGFR TKI therapy specifically in patients with ...
Cancer
Feb 22, 2013 |
not rated yet |
0
Childhood cancer in developing countries—a growing health threat that could be easily managed
Across the developing world, childhood cancer is on the rise, and mortality is high. Once thought of as a rich world disease, cancer is a growing health threat across low-income and middle-income countries (LMCs). A major ...
Cancer
Feb 19, 2013 |
not rated yet |
0
Improvement in child cancer survival rates threatened by lack of new drug development
Remarkable improvements in survival from childhood cancer have taken place in high- income countries over the past 50 years, but further progress is being threatened by increasingly strict research regulations and insufficient ...
Cancer
Feb 19, 2013 |
not rated yet |
0
ASCO: anticoagulant use predicts metastatic prostate CA survival
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to ...
Cancer
Feb 19, 2013 |
not rated yet |
0
Proscar won't boost prostate cancer survival, study finds
(HealthDay)—Men with prostate cancer taking the drug finasteride (Proscar) don't survive longer than similar men not taking the drug, a new study finds.
Cancer
Feb 15, 2013 |
not rated yet |
0
|
Researchers test tool for screening cancer patients for malnutrition
Considering the many things a cancer patient has to think about, it's easy to understand why maintaining proper nutrition may not be top of mind.
Cancer
Feb 15, 2013 |
5 / 5 (1) |
0
